alpha-synuclein and LRRK2: partners in crime
- PMID: 20064381
- PMCID: PMC2826885
- DOI: 10.1016/j.neuron.2009.12.017
alpha-synuclein and LRRK2: partners in crime
Abstract
In this issue of Neuron, Lin et al. report that LRRK2 modulates age-related neurodegeneration caused by overexpression of alpha-synuclein in the forebrain of transgenic mice. Overexpression of LRRK2 accelerates the progression of alpha-synuclein-mediated neuropathological changes, whereas deletion of LRRK2 alleviates these alterations. The results reveal an interesting interaction between alpha-synuclein and LRRK2, two gene products linked to dominantly inherited Parkinson's disease.
2009 Elsevier Inc. All rights reserved.
Similar articles
-
Leucine-rich repeat kinase 2 regulates the progression of neuropathology induced by Parkinson's-disease-related mutant alpha-synuclein.Neuron. 2009 Dec 24;64(6):807-27. doi: 10.1016/j.neuron.2009.11.006. Neuron. 2009. PMID: 20064389 Free PMC article.
-
Leucine-rich Repeat Kinase 2 (LRRK2) Pharmacological Inhibition Abates α-Synuclein Gene-induced Neurodegeneration.J Biol Chem. 2015 Aug 7;290(32):19433-44. doi: 10.1074/jbc.M115.660001. Epub 2015 Jun 15. J Biol Chem. 2015. PMID: 26078453 Free PMC article.
-
The unlikely partnership between LRRK2 and α-synuclein in Parkinson's disease.Eur J Neurosci. 2019 Feb;49(3):339-363. doi: 10.1111/ejn.14182. Epub 2018 Oct 24. Eur J Neurosci. 2019. PMID: 30269383 Free PMC article. Review.
-
Interaction of LRRK2 and α-Synuclein in Parkinson's Disease.Adv Neurobiol. 2017;14:209-226. doi: 10.1007/978-3-319-49969-7_11. Adv Neurobiol. 2017. PMID: 28353286 Review.
-
Leucine-rich repeat kinase 2 phosphorylates brain tubulin-beta isoforms and modulates microtubule stability--a point of convergence in parkinsonian neurodegeneration?J Neurochem. 2009 Sep;110(5):1514-22. doi: 10.1111/j.1471-4159.2009.06235.x. Epub 2009 Jun 22. J Neurochem. 2009. PMID: 19545277
Cited by
-
Mouse Genetic Models of Human Brain Disorders.Front Genet. 2016 Mar 23;7:40. doi: 10.3389/fgene.2016.00040. eCollection 2016. Front Genet. 2016. PMID: 27047540 Free PMC article. Review.
-
The LRRK2 G2019S mutant exacerbates basal autophagy through activation of the MEK/ERK pathway.Cell Mol Life Sci. 2013 Jan;70(1):121-36. doi: 10.1007/s00018-012-1061-y. Epub 2012 Jul 8. Cell Mol Life Sci. 2013. PMID: 22773119 Free PMC article.
-
G2019S LRRK2 Mutation Enhances MPP+-Induced Inflammation of Human Induced Pluripotent Stem Cells-Differentiated Dopaminergic Neurons.Front Neurosci. 2022 Jul 6;16:947927. doi: 10.3389/fnins.2022.947927. eCollection 2022. Front Neurosci. 2022. PMID: 35873822 Free PMC article.
-
Animal models of Parkinson's disease: vertebrate genetics.Cold Spring Harb Perspect Med. 2012 Oct 1;2(10):a009324. doi: 10.1101/cshperspect.a009324. Cold Spring Harb Perspect Med. 2012. PMID: 22960626 Free PMC article. Review.
-
Genetics and genomics of Parkinson's disease.Genome Med. 2014 Jun 30;6(6):48. doi: 10.1186/gm566. eCollection 2014. Genome Med. 2014. PMID: 25061481 Free PMC article. Review.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical